Cargando…

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer

OBJECTIVE: The malignant progression from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) is common and has detrimental effect on patients. We aimed to elucidate the underlying mechanisms of the malignant progression from an immunological perspective and establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Zongtai, Mao, Shiyu, Zhang, Wentao, Liu, Ji, Li, Cheng, Wang, Ruiliang, Yao, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773013/ https://www.ncbi.nlm.nih.gov/pubmed/33392066 http://dx.doi.org/10.3389/fonc.2020.542492

Ejemplares similares

Dysregulation of tumor microenvironment promotes malignant progression and predicts risk of metastasis in bladder cancer
por: Liu, Ji, et al.
Publicado: (2021)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

N(6)-methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma
por: Zheng, Zongtai, et al.
Publicado: (2020)

MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2019)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2023)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer
por: Shen, Liliang, et al.
Publicado: (2022)

A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer
por: Li, Faping, et al.
Publicado: (2020)

Prognostic significance of red cell distribution width in bladder cancer
por: Ma, Wenchao, et al.
Publicado: (2020)

Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer
por: Guo, Yadong, et al.
Publicado: (2022)

Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2022)

Effects of Radiotherapy or Radical Prostatectomy on the Risk of Long-Term Heart-Specific Death in Patients With Prostate Cancer
por: Guo, Yadong, et al.
Publicado: (2020)

PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer
por: Long, Qian, et al.
Publicado: (2020)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment
por: Sun, Wenguo, et al.
Publicado: (2020)

CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2022)

The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression
por: Kim, Gina, et al.
Publicado: (2020)

Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients
por: Yang, Fuhan, et al.
Publicado: (2021)

Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021)

Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study
por: Guo, Yadong, et al.
Publicado: (2022)

Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment
por: Wang, Zhihao, et al.
Publicado: (2022)

Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing
por: Chen, Zhibin, et al.
Publicado: (2023)

Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study
por: Mao, Shiyu, et al.
Publicado: (2020)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2018)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
por: Mao, Shiyu, et al.
Publicado: (2020)

Bladder cancer-associated microbiota: Recent advances and future perspectives
por: Zhang, Wentao, et al.
Publicado: (2023)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
por: Wan, Xin, et al.
Publicado: (2022)

Urological cancer organoids, patients' avatars for precision medicine: past, present and future
por: Chen, Haotian, et al.
Publicado: (2022)

m(6)A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer
por: Su, Yunshu, et al.
Publicado: (2019)

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
por: Huang, Jianhua, et al.
Publicado: (2021)

The development and assessment of a predicting nomogram for the recovery of immediate urinary continence following laparoscopic radical prostatectomy
por: Gu, Zhuoran, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer
por: Su, Dan, et al.
Publicado: (2021)

Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy
por: Wu, Jie, et al.
Publicado: (2021)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

Malignant Progression Contributes to the Failure of Combination Therapy for Atypical Meningiomas
por: Zhang, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_svtemju7momkrdmgidcfbctujq